The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC
- 1 August 2012
- journal article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 21 (3) , 301-309
Abstract
In hereditary diffuse gastric cancer (HDGC), CDH1 germline gene alterations are causative events in 30% of the cases. In 20% of HDGC families, CDH1 germline mutations are of the missense type and the mutation carriers constitute a problem in terms of genetic counseling and surveillance. To access the pathogenic relevance of missense mutations, we have previously developed an in vitro method to functionally characterize them. Pathogenic E-cadherin missense mutants fail to aggregate and become more invasive, in comparison with cells expressing the wild-type (WT) protein. Herein, our aim was to develop a complementary method to unravel the pathogenic significance of E-cadherin missense mutations. We used cells stably expressing WT E-cadherin and seven HDGC-associated mutations (five intracellular and two extracellular) and studied by proximity ligation assays (PLA) how these mutants bind to fundamental regulators of E-cadherin function and trafficking. We focused our attention on the interaction with: p120, β-catenin, PIPKIγ and Hakai. We showed that cytoplasmic E-cadherin mutations affect the interaction of one or more binding partners, compromising the E-cadherin stability at the plasma membrane and likely affecting the adhesion complex competence. In the present work, we demonstrated that the study of the interplay between E-cadherin and its binding partners, using PLA, is an easy, rapid, quantitative and highly reproducible technique that can be applied in routine labs to verify the pathogenicity of E-cadherin missense mutants for HDGC diagnosis, especially those located in the intracellular domain of the protein.Keywords
This publication has 51 references indexed in Scilit:
- Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literatureBMC Cancer, 2012
- ADP-Ribosylation Factor 6 Mediates E-Cadherin Recovery by Chemical ChaperonesPLOS ONE, 2011
- Regulation of Cadherin TraffickingTraffic, 2009
- α-Catenin mediates initial E-cadherin-dependent cell–cell recognition and subsequent bond strengtheningProceedings of the National Academy of Sciences, 2008
- Hereditary diffuse gastric cancer: association with lobular breast cancerFamilial Cancer, 2007
- Making and breaking contacts: the cellular biology of cadherin regulationCurrent Opinion in Cell Biology, 2007
- Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric CancerJAMA, 2007
- Type Iγ phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with μ1B adaptinJournal of Cell Biology, 2007
- Direct observation of individual endogenous protein complexes in situ by proximity ligationNature Methods, 2006
- Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredHuman Mutation, 2002